Skip Navigation

Cardiovascular Research 1996 31(1):102-116; doi:10.1016/S0008-6363(95)00166-2
© 1996 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mallet, R. T.
Right arrow Articles by Downey, H.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mallet, R. T.
Right arrow Articles by Downey, H.F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1996, European Society of Cardiology

Endogenous adenosine increases O2 utilisation efficiency in isoprenaline-stimulated canine myocardium

Robert T. Mallet*, Shang-Chiun Lee and H.Fred Downey

Department of Physiology, University of North Texas Health Science Center. 3500 Camp Bowie Boulevard, Fort Worth, TX 76107-2699, USA

* Corresponding author. Tel. (+1-817) 735-2260; Fax (+1-817) 735-5084.

Objective: We have previously demonstrated that myocardium is capable of down-regulating its O2 requirements and thus avoiding ischaemia when O2 supply is limited. The present study tested the hypothesis that endogenous adenosine produced this protective response when O2 supply was decreased by moderate coronary hypopertusion or moderate coronary hypoxaemia. Methods: In anaesthetised dogs, hearts were exposed by left thoracotomy and instrumented for measuring intraventricular pressure and regional myocardial segment length. The left anterior descending coronary artery was isolated, cannulated, and extracorporeally perfused. Coronary O2 supply was moderately reduced by lowering coronary perfusion pressure from 100 to 60 mmHg or by lowering coronary arterial O2 content by 50%. Hearts were treated with intracoronary infusions of adenosine, adenosine deaminase to degrade endogenous adenosine or with erythro-9-(2-hydroxy-3-nonyl)-adenine · HC1 (EHNA) to inhibit adenosine degradation by endogenous adenosine deaminase, during β-adrenergic stimulation with isoprenaline. Cardiac power in the left anterior descending perfusion territory was indexed by the product of heart rate · left ventricular peak systolic pressure · percent systolic segment shortening. O2 utilisation efficiency was taken as the ratio of power index/myocardial O2 consumption. Results: Prior to a reduction in O2 supply, isoprenaline did not alter O2 utilisation efficiency. Intracoronary adenosine increased O2 utilisation efficiency during isoprenaline stimulation by 23% (P <0.05). EHNA slightly increased O2 utilisation efficiency during isoprenaline stimulation (10%; P < 0.05); adenosine deaminase was without effect. When coronary perfusion pressure was decreased, adenosine deaminase sharply lowered cardiac power and O2 utilisation efficiency during isoprenaline stimulation, whereas EHNA augmented isoprenaline-enhanced power and increased efficiency. During hypoxaemia, adenosine deaminase lowered regional power but not efficiency during isoprenaline infusion; EHNA did not affect power but lowered O2 consumption and increased efficiency. Myocardial lactate extraction and contractile function during isoprenaline stimulation were not attenuated by reduced O2 supply, indicating that myocardial ischaemia did not occur under these conditions. Conclusion: Endogenous adenosine increases myocardial O2 utilisation efficiency during β-adrenergic stimulation, and thus helps avert ischaemia when myocardial O2 supply is reduced.

KEYWORDS ADA adenosine deaminase; ADO adenosine; AoP mean aortic pressure; CaO2 coronary arterial oxygen content; CvO2 coronary venous oxygen content; CVR coronary vascular resistance; dP/dt maximum rate of increase of left intraventricular pressure; EHNA erythro-9-(2-hydroxy-3-nonyl)-adenine·HCl; HR heart rate; ISO isoprenaline; La% coronary lactate extraction; LAD left anterior descending coronary artery; LVP left ventricular developed pressure; MVO2 myocardial O2 consumption; O2% coronary oxygen extraction; PP coronary perfusion pressure; PvO2 coronary venous oxygen tension; S% percent systolic segment shortening


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.